Zoekresultaten - Safi U. Khan, MD

UTILIZATION OF OPTIMAL MEDICAL PHARMACOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM AN INTEGRATED HEALTHCARE SYSTEM door Izza Shahid, MBBS, Budhaditya Bose, MS, Eleonora Avenatti, MD, Safi U. Khan, MD MHS, Mohamad B. Taha, MD, Khurram Nasir, MD MPH MSc

Connect to this object online.

Trends in Cardiovascular Deaths Among Young Adults in the United States, 1999-2018 door Safi U. Khan, MD, Zubair Shahid Bashir, MD, Muhammad Zia Khan, MD, Muhammad Shahzeb Khan, MD, Martha Gulati, MD, MS, Ron Blankstein, MD, Roger S. Blumenthal, MD, Erin D. Michos, MD, MHS

Connect to this object online.

Efficacy and Safety for the Achievement of Guideline-Recommended Lower Low-Density Lipoprotein Cholesterol Levels: A Systematic Review and Meta-Analysis door Safi U. Khan, MD, Muhammad U. Khan, MD, Salim S. Virani, MD, PhD, Muhammad Shahzeb Khan, MD, Muhammad Zia Khan, MD, Muhammad Rashid, PhD, Ankur Kalra, MD, Mohamad Alkhouli, MD, Michael J. Blaha, MD, MPH, Roger S. Blumenthal, MD, Erin D. Michos, MD, MHS

Connect to this object online.